OSTEOARTHRITIS NEWS

Simple Ways to Help Relieve Osteoarthritis Symptoms

Blog

DePuy ASR Lawsuit Update: Despite Verdict in Favor of DePuy, Rottenstein Law Group Encourages Victims to Consider ASR Hip Lawsuits

Posted by [email protected] on April 18, 2013 at 3:10 PM

The Rottenstein Law Group, while disappointed by this verdict, notes that this trial could be an outlier and that plaintiffs could still be awarded millions of dollars in future DePuy ASR lawsuits. The firm maintains an informational website at www.depuyrecallnewscenter.com, which offers updates on the ASR and explains the process for filing an ASR lawsuit.


Chicago, Ill. (PRWEB) April 16, 2013


A jury in the second Depuy ASR trial in the nation found in favor of defendant DePuy Pharmaceuticals after a monthlong trial in Cook County Circuit Court in Illinois, according to court records (Strum v. DePuy (2011-L-009352, Cook County [Ill.] Circuit Court)). The Rottenstein Law Group, while disappointed by this verdict, notes that this trial could be an outlier and that plaintiffs could still be awarded millions of dollars in future DePuy ASR lawsuits. The firm maintains an informational website at www.depuyrecallnewscenter.com, which offers updates on the ASR and explains the process for filing an ASR lawsuit.


Strum, an Illinois nurse, had claimed that Johnson & Johnson subsidiary DePuy marketed its metal-on-metal DePuy ASR hip implant, despite knowing it had a defective design. Strum’s lawyer had said in closing arguments that Strum should be awarded $5 million, citing the pain and suffering she experienced after receiving the implant in 2008 and requiring revision surgery in 2011, according to Bloomberg.* The first ASR trial in the nation in Los Angeles saw the plaintiff receive more than an $8.3 million award for damages.


Read full story at PRWeb.com: DePuy ASR Lawsuit Update: Despite Verdict in Favor of DePuy, Rottenstein Law Group Encourages Victims to Consider ASR Hip Lawsuits

 

Categories: DePuy, Lawsuits, Hip Replacement


Comments are disabled.